Sierra Oncology Announces Momelotinib Data for Intermediate / High-risk Myelofibrosis Patients with Lower Baseline Platelet Counts by Seini Moimoi | Dec 7, 2020 | Portfolio News
Poseida Therapeutics Provides Update on Phase 1 Trial of P-BCMA-101 at the 2020 American Society of Hematology Annual Meeting by Seini Moimoi | Dec 5, 2020 | Portfolio News
Nalu Receives FDA Clearance for 1.5T Full-Body MRI Scanning In Patients With Nalu Neurostimulation System Implants by Seini Moimoi | Dec 4, 2020 | Portfolio News
Akebia Therapeutics Ranked 10th Fastest-Growing Company in North America on Deloitte’s 2020 Technology Fast 500™ by Seini Moimoi | Nov 18, 2020 | Portfolio News
Akebia Announces Manuscript Highlighting Global Phase 3 INNO2VATE Program Rationale, Study Design and Baseline Characteristics Published in Peer-Reviewed Medical Journal by Seini Moimoi | Nov 16, 2020 | Portfolio News
